These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 27159593

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, Koyro T, Peters A, Velden J, Hünemörder S, Haag F, Steinmetz OM, Mittrücker HW, Stahl RA, Panzer U.
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [Abstract] [Full Text] [Related]

  • 23. High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition.
    Bate-Eya LT, den Hartog IJ, van der Ploeg I, Schild L, Koster J, Santo EE, Westerhout EM, Versteeg R, Caron HN, Molenaar JJ, Dolman ME.
    Oncotarget; 2016 May 10; 7(19):27946-58. PubMed ID: 27056887
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Glomerular Proteomic Profiles in the NZB/W F1 Hybrid Mouse Model of Lupus Nephritis.
    Xue L, Shuyan T, Xiaoli L, Zilong L, Qiuling F, Lining W, Yanqiu L, Li Y.
    Med Sci Monit; 2019 Mar 22; 25():2122-2131. PubMed ID: 30900683
    [Abstract] [Full Text] [Related]

  • 26. Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28.
    Laurent L, Le Fur A, Bloas RL, Néel M, Mary C, Moreau A, Poirier N, Vanhove B, Fakhouri F.
    Eur J Immunol; 2017 Aug 22; 47(8):1368-1376. PubMed ID: 28631301
    [Abstract] [Full Text] [Related]

  • 27. Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice.
    Lee SW, Park KH, Park S, Kim JH, Hong SY, Lee SK, Choi D, Park YB.
    Arthritis Rheum; 2013 Jul 22; 65(7):1902-12. PubMed ID: 23553192
    [Abstract] [Full Text] [Related]

  • 28. Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.
    Katewa A, Wang Y, Hackney JA, Huang T, Suto E, Ramamoorthi N, Austin CD, Bremer M, Chen JZ, Crawford JJ, Currie KS, Blomgren P, DeVoss J, DiPaolo JA, Hau J, Johnson A, Lesch J, DeForge LE, Lin Z, Liimatta M, Lubach JW, McVay S, Modrusan Z, Nguyen A, Poon C, Wang J, Liu L, Lee WP, Wong H, Young WB, Townsend MJ, Reif K.
    JCI Insight; 2017 Apr 06; 2(7):e90111. PubMed ID: 28405610
    [Abstract] [Full Text] [Related]

  • 29. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
    Szalai AJ, Weaver CT, McCrory MA, van Ginkel FW, Reiman RM, Kearney JF, Marion TN, Volanakis JE.
    Arthritis Rheum; 2003 Jun 06; 48(6):1602-11. PubMed ID: 12794828
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings.
    Fathi NA, Hussein MR, Hassan HI, Mosad E, Galal H, Afifi NA.
    Clin Exp Immunol; 2006 Nov 06; 146(2):339-43. PubMed ID: 17034587
    [Abstract] [Full Text] [Related]

  • 32. Lupus nephritis progression in FcγRIIB-/-yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease.
    Horvei KD, Pedersen HL, Fismen S, Thiyagarajan D, Schneider A, Rekvig OP, Winkler TH, Seredkina N.
    PLoS One; 2017 Nov 06; 12(11):e0188863. PubMed ID: 29190833
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov 06; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 34. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
    Mun CH, Kim JO, Ahn SS, Yoon T, Kim SJ, Ko E, Noh HD, Park YB, Jung HJ, Kim TS, Lee SW, Park SG.
    Biomaterials; 2019 Nov 06; 220():119408. PubMed ID: 31394431
    [Abstract] [Full Text] [Related]

  • 35. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
    Simonin K, N'Diaye M, Lheureux S, Loussouarn C, Dutoit S, Briand M, Giffard F, Brotin E, Blanc-Fournier C, Poulain L.
    Apoptosis; 2013 Apr 06; 18(4):492-508. PubMed ID: 23344663
    [Abstract] [Full Text] [Related]

  • 36. Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis.
    Quezada SA, Eckert M, Adeyi OA, Schned AR, Noelle RJ, Burns CM.
    Arthritis Rheum; 2003 Sep 06; 48(9):2541-54. PubMed ID: 13130474
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A dexamethasone prodrug reduces the renal macrophage response and provides enhanced resolution of established murine lupus nephritis.
    Yuan F, Tabor DE, Nelson RK, Yuan H, Zhang Y, Nuxoll J, Bynoté KK, Lele SM, Wang D, Gould KA.
    PLoS One; 2013 Sep 06; 8(11):e81483. PubMed ID: 24312306
    [Abstract] [Full Text] [Related]

  • 40. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE.
    Lab Invest; 1993 Apr 06; 68(4):419-26. PubMed ID: 8479150
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.